Matthew L. Sherman, EVP & Chief Medical Officer at ACCELERON PHARMA INC (XLRN), sold 16,000 shares at $32.00 ($512K) on 2017-07-05, disclosed to the SEC on 2017-07-07.
Seasonal sale ($512k) by EVP & Chief Medical Officer — this insider has traded XLRN in July in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-10-04 | $37K | — | Filing → |